|
|
Suppliers for
Bimatoprost
|
Properties | CAS |
155206-00-1 | Formula |
C25H37NO4 |
|
|
33 Registered suppliers
More details are to be found here
More details are to be found here
Appearance | White to almost white powder
| Identification | IR of sample complies with that of known sample
| Specific rotation [α ]D²º | +33.0º~+37.0º (C=1.0,CH3CN)
| Water | ≤ 1.0%
| Related substances |
| 15R-Bimatoprost | ≤ 0.30%
| Bimatoprost free acid | ≤ 0.10%
| 5,6-trans-Bimatoprost | ≤ 0.50%
| Any other single impurity | ≤ 0.10%
| Total other imputities | ≤ 0.50%
| Residual solvents |
| Acetonitrile | ≤ 0.04%
| Ethanol | ≤ 0.5%
| n-Hexane | ≤ 0.05%
| Ethyl acetate | ≤ 0.4%
| Assay | 96.0~102.0%(anhydrous and solvent free basis) |
Appearance | White to almost white powder
| Identification | IR of sample complies with that of known sample
| Specific rotation [α ]D²º | +33.0º~+37.0º (C=1.0,CH3CN)
| Water | ≤ 1.0%
| Related substances |
| 15R-Bimatoprost | ≤ 0.30%
| Bimatoprost free acid | ≤ 0.10%
| 5,6-trans-Bimatoprost | ≤ 0.50%
| Any other single impurity | ≤ 0.10%
| Total other imputities | ≤ 0.50%
| Residual solvents |
| Acetonitrile | ≤ 0.04%
| Ethanol | ≤ 0.5%
| n-Hexane | ≤ 0.05%
| Ethyl acetate | ≤ 0.4%
| Assay | 96.0~102.0%(anhydrous and solvent free basis) |
Appearance | White to almost white powder
| Identification | IR of sample complies with that of known sample
| Specific rotation [α ]D²º | +33.0º~+37.0º (C=1.0,CH3CN)
| Water | ≤ 1.0%
| Related substances |
| 15R-Bimatoprost | ≤ 0.30%
| Bimatoprost free acid | ≤ 0.10%
| 5,6-trans-Bimatoprost | ≤ 0.50%
| Any other single impurity | ≤ 0.10%
| Total other imputities | ≤ 0.50%
| Residual solvents |
| Acetonitrile | ≤ 0.04%
| Ethanol | ≤ 0.5%
| n-Hexane | ≤ 0.05%
| Ethyl acetate | ≤ 0.4%
| Assay | 96.0~102.0%(anhydrous and solvent free basis) |
Appearance | White to almost white powder
| Identification | IR of sample complies with that of known sample
| Specific rotation [α ]D²º | +33.0º~+37.0º (C=1.0,CH3CN)
| Water | ≤ 1.0%
| Related substances |
| 15R-Bimatoprost | ≤ 0.30%
| Bimatoprost free acid | ≤ 0.10%
| 5,6-trans-Bimatoprost | ≤ 0.50%
| Any other single impurity | ≤ 0.10%
| Total other imputities | ≤ 0.50%
| Residual solvents |
| Acetonitrile | ≤ 0.04%
| Ethanol | ≤ 0.5%
| n-Hexane | ≤ 0.05%
| Ethyl acetate | ≤ 0.4%
| Assay | 96.0~102.0%(anhydrous and solvent free basis) |
More details are to be found here
Molecular Formula: C25H37NO4 Molecular Weight: 415.57
More details are to be found here
Molecular Formula: C25H37NO4 Molecular Weight: 415.57
More details are to be found here
Molecular Formula: C25H37NO4 Molecular Weight: 415.57
More details are to be found here
Purity: | ≥94%
| Use: | Antiglaucom agent
| Status/specification: | we have developed in commercial scale. |
Purity: | ≥94%
| Use: | Antiglaucom agent
| Status/specification: | we have developed in commercial scale. |
Purity: | ≥94%
| Use: | Antiglaucom agent
| Status/specification: | we have developed in commercial scale. |
Purity: | ≥94%
| Use: | Antiglaucom agent
| Status/specification: | we have developed in commercial scale. |
Purity: | ≥94%
| Use: | Antiglaucom agent
| Status/specification: | we have developed in commercial scale. |
Purity: | ≥94%
| Use: | Antiglaucom agent
| Status/specification: | we have developed in commercial scale. |
Purity: | ≥94%
| Use: | Antiglaucom agent
| Status/specification: | we have developed in commercial scale. |
Purity: | ≥94%
| Use: | Antiglaucom agent
| Status/specification: | we have developed in commercial scale. |
Purity: | ≥94%
| Use: | Antiglaucom agent
| Status/specification: | we have developed in commercial scale. |
Purity: | ≥94%
| Use: | Antiglaucom agent
| Status/specification: | we have developed in commercial scale. |
Purity: | ≥94%
| Use: | Antiglaucom agent
| Status/specification: | we have developed in commercial scale. |
More details are to be found here
More details are to be found here
More details are to be found here
Description : Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. - Molecular Weight :415.57
- Boiling Point :629.8±55.0 °C at 760 mmHg
- Melting Point :64-65°C
- Purity :> 98%
Molecular Formula : C25H37NO4 Canonical SMILES : CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O InChI : InChI=1S/C25H37NO4/c1-2-26-25(30)13-9-4-3-8-12-21-22(24(29)18-23(21)28)17-16-20(27)15-14-19-10-6-5-7-11-19/h3,5-8,10-11,16-17,20-24,27-29H,2,4,9,12-15,18H2,1H3,(H,26,30)/b8-3-,17-16+/t20-,21+,22+,23-,24+/m0/s1 InChIKey : AQOKCDNYWBIDND-FTOWTWDKSA-N Appearance : White or off-white power Application : For research used only Storage : -20ºC Synonyms : AGN 192024; AGN192024; AGN-192024; Bimatoprost; Lumigan; Latisse; Bimatoprostum; Lumigan.
More details are to be found here
Description : Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. - Molecular Weight :415.57
- Boiling Point :629.8±55.0 °C at 760 mmHg
- Melting Point :64-65°C
- Purity :> 98%
Molecular Formula : C25H37NO4 Canonical SMILES : CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O InChI : InChI=1S/C25H37NO4/c1-2-26-25(30)13-9-4-3-8-12-21-22(24(29)18-23(21)28)17-16-20(27)15-14-19-10-6-5-7-11-19/h3,5-8,10-11,16-17,20-24,27-29H,2,4,9,12-15,18H2,1H3,(H,26,30)/b8-3-,17-16+/t20-,21+,22+,23-,24+/m0/s1 InChIKey : AQOKCDNYWBIDND-FTOWTWDKSA-N Appearance : White or off-white power Application : For research used only Storage : -20ºC Synonyms : AGN 192024; AGN192024; AGN-192024; Bimatoprost; Lumigan; Latisse; Bimatoprostum; Lumigan.
More details are to be found here
Description : Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. - Molecular Weight :415.57
- Boiling Point :629.8±55.0 °C at 760 mmHg
- Melting Point :64-65°C
- Purity :> 98%
Molecular Formula : C25H37NO4 Canonical SMILES : CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O InChI : InChI=1S/C25H37NO4/c1-2-26-25(30)13-9-4-3-8-12-21-22(24(29)18-23(21)28)17-16-20(27)15-14-19-10-6-5-7-11-19/h3,5-8,10-11,16-17,20-24,27-29H,2,4,9,12-15,18H2,1H3,(H,26,30)/b8-3-,17-16+/t20-,21+,22+,23-,24+/m0/s1 InChIKey : AQOKCDNYWBIDND-FTOWTWDKSA-N Appearance : White or off-white power Application : For research used only Storage : -20ºC Synonyms : AGN 192024; AGN192024; AGN-192024; Bimatoprost; Lumigan; Latisse; Bimatoprostum; Lumigan.
More details are to be found here
Description : Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. - Molecular Weight :415.57
- Boiling Point :629.8±55.0 °C at 760 mmHg
- Melting Point :64-65°C
- Purity :> 98%
Molecular Formula : C25H37NO4 Canonical SMILES : CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O InChI : InChI=1S/C25H37NO4/c1-2-26-25(30)13-9-4-3-8-12-21-22(24(29)18-23(21)28)17-16-20(27)15-14-19-10-6-5-7-11-19/h3,5-8,10-11,16-17,20-24,27-29H,2,4,9,12-15,18H2,1H3,(H,26,30)/b8-3-,17-16+/t20-,21+,22+,23-,24+/m0/s1 InChIKey : AQOKCDNYWBIDND-FTOWTWDKSA-N Appearance : White or off-white power Application : For research used only Storage : -20ºC Synonyms : AGN 192024; AGN192024; AGN-192024; Bimatoprost; Lumigan; Latisse; Bimatoprostum; Lumigan.
More details are to be found here
More details are to be found here
More details are to be found here
More details are to be found here
|
Properties:
... more properties and specification on Bimatoprost
|
|
Privileged suppliers
Last update 2024-06-10
|